poly(DL-lactide-co-glycolide)
polymerPoly(DL-lactide-co-glycolide), commonly known as PLGA, is a synthetic biodegradable copolymer synthesized from lactic and glycolic acid monomers in a 1:1 ratio. It is widely used in the biomedical and pharmaceutical industries for controlled-release drug delivery systems and tissue engineering scaffolds, where its tunable degradation rate and biocompatibility make it an attractive alternative to permanent synthetic polymers and natural biopolymers. Engineers select PLGA when applications require materials that resorb harmlessly in the body over weeks to months, eliminating the need for surgical removal while providing mechanical support during the healing process.
drug delivery systemsbiodegradable implantstissue engineering scaffoldsorthopedic devicesmicroparticle formulationssutures and wound closure
Compliance & Regulations
?UL 94?Conflict Free?RoHS?REACH?TSCA?Prop 65
| Property | Value | Unit | Conditions | Source | |
|---|---|---|---|---|---|
Glass Transition Temperature(Tg) | — | °F | — | — |
Verified Unverified Low confidence (<80%) Link to source
Regulatory Screening
Environmental
Safety & Biocompatibility
RoHS, REACH, and Prop 65 statuses are validated against official substance lists (ECHA SVHC Candidate List, OEHHA Prop 65, RoHS Annex II). Other regulations are estimated from composition and material classification. All screening is a starting point for due diligence — always verify with your supplier before making compliance decisions.